Technical analysis of Senseonics Holdings, Inc. (SENS): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Senseonics Holdings, Inc. operates as a medical technology enterprise, specializing in the development and commercialization of continuous glucose monitoring (CGM) systems. These innovative solutions cater to individuals with diabetes across the United States, Europe, the Middle East, and Africa. The company's core product offerings, Eversense and Eversense XL, are advanced implantable CGM devices.
Price Performance
| 1 month | +2.19% |
| 3 months | +31.75% |
| Year-to-date | +60.87% |
| 1 year | -0.78% |
| 3 years | -11.20% |
| 5 years | -88.35% |
52-Week Range
| 52-week High | $11.58 |
| 52-week Low | $4.79 |
| Avg Volume (90d) | 762K |
Technical Indicators
| SMA 50 | $7.12 |
| SMA 200 | $6.76 |
| Beta | 1.05 |
| 30-day Volatility (annualised) | 104.1% |
| Price vs SMA 50 | +24.6% |
| Price vs SMA 200 | +31.4% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $7.05 | |
| 2025-11 | $6.18 | -12.3% |
| 2025-12 | $5.52 | -10.7% |
| 2026-01 | $7.33 | +32.8% |
| 2026-02 | $8.27 | +12.8% |
| 2026-03 | $6.66 | -19.5% |
| 2026-04 | $6.61 | -0.8% |
| 2026-05 | $6.79 | +2.7% |
| 2026-06 | $5.68 | -16.3% |
| 2026-07 | $5.03 | -11.4% |
| 2026-08 | $9.23 | +83.5% |
| 2026-09 | $8.88 | -3.8% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | | |
| 2026-09-14 | | |
| 2026-09-14 | $-0.10 | |
| 2026-09-14 | | |
| 2026-09-14 | $-0.05 | $3M |
| 2026-09-14 | $-0.03 | $278M |
Price
| Price | $9.06 |
| Market Cap | $379M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 5.75 |
| EV / EBITDA | -3.69 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.68 |
| Current Ratio | 6.74 |